Volume 57, Issue 6, Pages (June 2000)

Slides:



Advertisements
Similar presentations
The flux of arginine after ischemia-reperfusion in the rat kidney
Advertisements

Volume 63, Issue 4, Pages (April 2003)
Plasma sodium and hypertension
Intensive hemodialysis—keeping the faith
Use of hemodialysis and hemoperfusion in poisoned patients
Volume 56, Pages S62-S66 (November 1999)
Renal radiation-induced arterial stenosis
Confounding: What it is and how to deal with it
Volume 54, Pages S86-S91 (December 1998)
Volume 54, Issue 3, Pages (September 1998)
Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006
Prof. Silvio Cavalcanti, DEIS, Silvia Cavani, Antonio Santoro 
Intensive hemodialysis—keeping the faith
Lucile Mercadal, Aziz Hamani, Bernard Béné, Thierry Petitclerc 
Volume 67, Issue 2, Pages (February 2005)
Volume 63, Issue 4, Pages (April 2003)
Initial clinical results with the LifeSite® Hemodialysis Access System
Volume 85, Issue 3, Pages (March 2014)
Salt and Hypertension American Journal of Kidney Diseases
Erratum Regarding “Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients” [Am J Kidney Dis 2009; 54: ] 
Nosratola D. Vaziri, Kaihui Liang, Yaoxian Ding  Kidney International 
Piet Borgdorff, PhD, Rogier H. van den Berg, MsC, Martijn A
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 54, Issue 2, Pages (August 1998)
Volume 61, Issue 2, Pages (February 2002)
Volume 61, Issue 1, Pages (January 2002)
Volume 66, Issue 1, Pages (July 2004)
American Journal of Kidney Diseases 
Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes  Choong H. Kim, Nosratola D. Vaziri  Kidney.
Late referral and modality choice in end-stage renal disease
Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions  Nikolaos Karamperis, Erik Sloth,
The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J.
Blood pressure targets in hemodialysis patients
Volume 69, Issue 10, Pages (May 2006)
Method for detecting the disconnection of an extracorporeal device using a patient's endogenous electrical voltages  E.A. Ross, C. Briz, R.J. Sadleir 
A method for monitoring vascular access function during hemodialysis
Volume 61, Issue 6, Pages (June 2002)
Volume 80, Issue 2, Pages (July 2011)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Volume 67, Issue 6, Pages (June 2005)
Novel Anti-Inflammatory Properties of the Angiogenesis Inhibitor Vasostatin  Rainer Huegel, Paula Velasco, Maria De La Luz Sierra, Enno Christophers, Jens.
Nephrology Crossword: Glomerulonephritis
Volume 63, Issue 4, Pages (April 2003)
A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.
Volume 71, Issue 11, Pages (June 2007)
Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic.
Volume 69, Issue 4, Pages (February 2006)
The course of the remnant kidney model in mice
Atherosclerotic renal artery stenosis and reconstruction
Charles A. Herzog  Kidney International 
Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson 
Volume 73, Issue 6, Pages (March 2008)
Renal blood flow in experimental septic acute renal failure
Erratum Kidney International Volume 61, Issue 4, (April 2002)
Volume 61, Issue 2, Pages (February 2002)
Volume 53, Issue 4, Pages (April 1998)
Volume 58, Issue 2, Pages (August 2000)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 75, Issue 5, Pages (March 2009)
Volume 60, Issue 5, Pages (November 2001)
Rebound kinetics of β2-microglobulin after hemodialysis
Graft flow as a predictor of thrombosis in hemodialysis grafts
Volume 57, Issue 4, Pages (April 2000)
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Effects of FK506 in rat and human resistance arteries
Volume 56, Issue 3, Pages (September 1999)
Presentation transcript:

Volume 57, Issue 6, Pages 2608-2617 (June 2000) In vivo visualization of hemodialysis-induced alterations in leukocyte–endothelial interactions  Marco E. van Teijlingen, Piet Borgdorff, Michiel H. van Wijhe, Ton A. van Lambalgen, Piet M. Ter Wee, Geert-Jan Tangelder  Kidney International  Volume 57, Issue 6, Pages 2608-2617 (June 2000) DOI: 10.1046/j.1523-1755.2000.00121.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Adaptation of the dialyzer. The cap of a hemoflow E1 dialyzer (A) was employed as a mold to fabricate occlusive silicone rings. The desired residual opening was obtained by insertion of a plastic pin into the dialyzer's cap. Insertion of the resulting silicone ring (B) into the dialyzer's inlet effectively reduced the number of capillaries that was perfused with blood during the extracorporeal circulation (C). Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Hemodynamic consequences of extracorporeal circulation. Effect of extracorporeal circulation with dialyzer (cuprophan) or without dialyzer (sham hemodialysis, s-HD) on mean arterial pressure (MAP; A) and heart rate (HR; B). Filling of the circuit with blood occurred between -10 and 0 minutes (inserts). Extracorporeal circulation was started at zero minutes. Data are expressed as mean ± SEM. Symbols are: (○) control group, N = 5; (•) cuprophan group, N = 5; (□) s-HD group, N = 3. *Significant difference between control animals and other groups over the 60-minutes period. #Significant difference within a group over the 60-minute period. Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Hemodialysis (HD)-induced leukopenia. Use of a cuprophan dialyzer without dialysate flow caused an early and transient drop in the number of circulating leukocytes. Symbols are: (□) control group, N = 6; (▪) extracorporeal circulation with a cuprophan dialyzer, N = 6; () extracorporeal circulation without a dialyzer, N = 4. *Significant difference between control and treated animals. #Significant difference compared to its initial value. Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Hemodialysis (HD)-induced leukopenia. Use of a cuprophan dialyzer without dialysate flow caused an early and transient drop in the number of circulating leukocytes. Symbols are: (□) control group, N = 6; (▪) extracorporeal circulation with a cuprophan dialyzer, N = 6; () extracorporeal circulation without a dialyzer, N = 4. *Significant difference between control and treated animals. #Significant difference compared to its initial value. Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Absence of leukocyte sequestration in the exteriorized mesentery during HD-induced leukopenia. Recording of an arteriole (left vessel) and venule (right vessel) 1 minute prior to dialysis without a dialysate flow (left) and 10 minutes after the start of the procedure (right). The arrows point at rolling leukocytes. Note the absence of rolling and adhering cells during the cuprophan-induced leukopenia (right). Extracorporeal circulation through the cuprophan dialyzer did not induce leukocyte–endothelial interactions in the arteriole. Experimental time (h:min:s) is indicated in the upper right corner of each panel. The bar indicates 50 μm. Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Decreased leukocyte rolling during extracorporeal circulation. The use of a cuprophan dialyzer without dialysate flow caused an early drop in the number of rolling leukocytes in venules of the exteriorized mesentery. By the end of the dialysis procedure, the number of rolling leukocytes was still decreased. Symbols are: (□) control group, N = 5; (▪) extracorporeal circulation with a cuprophan dialyzer, N = 5; () extracorporeal circulation without a dialyzer, N = 4. *Significant difference with control animals. #Significant difference compared to its initial value. Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Decreased leukocyte rolling during extracorporeal circulation. The use of a cuprophan dialyzer without dialysate flow caused an early drop in the number of rolling leukocytes in venules of the exteriorized mesentery. By the end of the dialysis procedure, the number of rolling leukocytes was still decreased. Symbols are: (□) control group, N = 5; (▪) extracorporeal circulation with a cuprophan dialyzer, N = 5; () extracorporeal circulation without a dialyzer, N = 4. *Significant difference with control animals. #Significant difference compared to its initial value. Kidney International 2000 57, 2608-2617DOI: (10.1046/j.1523-1755.2000.00121.x) Copyright © 2000 International Society of Nephrology Terms and Conditions